Crossmark Global Holdings’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,700
| Closed | -$562K | – | 1458 |
|
|
2020
Q3 | $562K | Buy |
10,700
+60
| +0.6% | +$3.15K | 0.02% | 723 |
|
|
2020
Q2 | $354K | Buy |
10,640
+820
| +8% | +$27.3K | 0.01% | 920 |
|
|
2020
Q1 | $267K | Buy |
+9,820
| New | +$267K | 0.01% | 918 |
|
|
2018
Q4 | – | Sell |
-23,453
| Closed | -$617K | – | 1602 |
|
|
2018
Q3 | $617K | Sell |
23,453
-320
| -1% | -$8.42K | 0.02% | 823 |
|
|
2018
Q2 | $486K | Buy |
23,773
+1,560
| +7% | +$31.9K | 0.01% | 966 |
|
|
2018
Q1 | $403K | Sell |
22,213
-1,833
| -8% | -$33.3K | 0.01% | 1069 |
|
|
2017
Q4 | $335K | Buy |
24,046
+6,813
| +40% | +$94.9K | 0.01% | 1304 |
|
|
2017
Q3 | $319K | Buy |
+17,233
| New | +$319K | 0.01% | 1274 |
|
|
2016
Q3 | $319K | Buy |
+17,233
| New | +$319K | 0.01% | 1274 |
|